Negative predictors of survival in HIV-infected patients with culture-confirmed pulmonary tuberculosis

Infection

Volumn 27, Issue 6, 1999, Pages 331-334

  Palmieri, F ^a   Pellicelli, A M ^a   Girardi, E ^b   De Felici, A P ^a   De Mori, P ^a   Petrosillo, N ^a   Ippolito, G ^b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b Centro di Riferimento AIDS Serv Epidemiol delle Malat Infe   (Italy)

Author keywords

Drug resistant tuberculosis; HIV infections; Prognosis; Survival; Tuberculosis

Indexed keywords

CD4 ANTIGEN; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MALE; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTION; RETROSPECTIVE STUDY; SURVIVAL RATE;

EID: 0032711648     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s150100050038     Document Type: Article

References (18)

1. Whalen C, Horsburgh CR Jr, Hom D, Lahart C, Simberkoff M, Ellner J: Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129-135.
2. Lucas S, Nelson AM: Pathogenesis of tuberculosis in human immunodeficiency virus-infected people. In: Bloom BR (ed): Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington DC 1994, pp 503-513.
3. Stoneburner R, Laroche E, Prevots R, Singh T, Blum S, Terry P, Reatrice S, Adler J: Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition. Arch Intern Med 1992; 152: 2033-2037.
4. Perriens JH, Colebunders RL, Karahunga C, Willame JC, Jeugmans J, Kaboto M, Mukadi Y, Pauwels P, Ryder RW, Prignot J: Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis 1991; 144: 750-755.
5. Leroy V, Salmi LR, Dupon M, Sentilhes A, Texier-Maugein J, Dequae L, Dabis F, Salamon R: Progression of human immunodeficiency virus infection in patients with tuberculosis diseases. A cohort study in Bordeaux, France, 1988-1994. The Groupe d'Épidémiologie Clinique du SIDA en Aquitaine (GESCA). Am J Epidemiol 1997; 145: 293-300.
6. Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM, Greenberg AE, De Cock KM: Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'lvoire. Lancet 1995; 345: 607-610.
7. Alpert PL, Munsiff SS, Gourevitch MN, Greenberg B, Klein RS: A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestation and factors associated with survival. Clin Infect Dis 1997; 24: 661-668.
8. Shafer RW, Bloch AB, Larkin C, Vasudavan V, Seligman S, Dehovitz JD, DiFerdinando G, Stoneburner R, Cauthen G: Predictors of survival in HIV-infected tuberculosis patients. AIDS 1996; 10: 269-272.
9. Salomon N, Perlman DC, Friedmann P, Buchstein S, Kreiswirth BN, Mildvan D: Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1245-1252.
10. Whalen C, Okwera A,Johnson J, Vjecha M, Hom D, Wallis R, Huebner R, Mugerwa R, Ellner J: Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med 1996; 153: 1977-1981.
11. Whalen C, Horsburgh CR Jr, Hom D, Lahart C, Simberkoff M, Ellner J: Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS 1997; 11: 455-460.
12. Turett GS, Telzak EE, Torian LV, Blum S, Alland D, Weisfuse I, Fazal BA: Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1238-1244.
13. Pablos-Méndez A, Sterling TR, Frieden TR: The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 1996; 276: 1223-1228.
14. Park MM, Davis AL, Schluger NW, Cohen H, Rom WN: Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropiate therapy. Am J Respir Crit Care Med 1996; 153: 317-324.
15. Mannheimer SB, Sepkowitz KA, Stoeckle M, Friedman CR, Hafner A, Riley LW: Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City. Int J Tuberc Lung Dis 1997; 1: 319-325.
16. Fischl MA, Daikos GL, Uttamchandani RB, Poblete RB, Moreno JN, Reyes RR, Boota AM, Thompson LM, Cleary TJ, Oldham SA, Saldana MJ, Lai S: Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med 1992; 117: 184-190.
17. Kaplan E, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
18. Cox DR, Oakes D: Analysis of survival data. Chapman & Hall, London 1984.